Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations
- 1 March 2017
- journal article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 37, 83-90
- https://doi.org/10.1016/j.jocn.2016.12.023
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs (B7335R, B9260L)
- National Multiple Sclerosis Society (12-SCB-Yale-05, RG2135)
- Japan Society for the Promotion of Science (25462226)
This publication has 46 references indexed in Scilit:
- Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhageMolecular Medicine Reports, 2013
- HIV-1 Tat Promotes Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) vIL-6-Induced Angiogenesis and Tumorigenesis by Regulating PI3K/PTEN/AKT/GSK-3β Signaling PathwayPLOS ONE, 2013
- Tissue Factor Regulates Microvessel Formation and Stabilization by Induction of Chemokine (C-C motif) Ligand 2 ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 Is Critical for Vascular DevelopmentScience Signaling, 2010
- Alternatively spliced tissue factor induces angiogenesis through integrin ligationProceedings of the National Academy of Sciences of the United States of America, 2009
- Regulation of cardiovascular development and integrity by the heart of glass–cerebral cavernous malformation protein pathwayNature Medicine, 2009
- Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesisHuman Molecular Genetics, 2008
- A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cellsHuman Molecular Genetics, 2008
- Cerebral cavernous malformation: new molecular and clinical insightsJournal of Medical Genetics, 2006
- Interleukin‐6 involvement in brain arteriovenous malformationsAnnals of Neurology, 2005